Sort
261,768 grants matching “gene therapy”
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,237,901Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Multiplexed imaging of chromatin folding and RNA profiles in cancer
$1,237,899Siyuan Wang · Yale University · R33 · FY2020 · CA
Novel Strategies for Brain Tumor Therapy
$1,237,378Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · NS
Novel Strategies for Brain Tumor Therapy
$1,237,376Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · NS
Novel Strategies for Brain Tumor Therapy
$1,237,376Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · NS
A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies
$1,237,360Ryan Gessner · Sonovol, Inc. · R44 · FY2021 · CA
The Monarch Initiative: Linking Diseases to Model Organism Resources
$1,237,355Melissa A Haendel · Oregon Health & Science University · R24 · FY2017 · OD
The Houston Center for Acquired Resistance Research (H-CARR)
$1,237,322Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
$1,237,249Krista H Vandenborne · University Of Florida · R01 · FY2022 · AR
Pathology, Developmental Origins, and Prevention of Pediatric Dysphagia
$1,236,967Anthony S Lamantia · George Washington University · P01 · FY2016 · HD
Harnessing Clinical Genomic Characterization to Accelerate Translational Advances for Patients with IDD
$1,236,882Philip R.o. Payne · Washington University · U01 · FY2022 · TR
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$1,236,847Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Novel SCD1 inhibitors for treatment of cancer
$1,236,819John A Copland · Modulation Therapeutics, Inc. · R42 · FY2019 · CA
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,236,590Mark Larche · Mcmaster University · U19 · FY2016 · AI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages
$1,236,573Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,236,369Brian J Druker · Oregon Health & Science University · U01 · FY2019 · CA
Innovation through collaboration at the intersection of childhood development and cancer: a platform for the Gabriella Miller Kids First Pediatric Data Resource Center
$1,236,279Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2018 · HL
Development of Novel sgp130-Fc Bioconjugates for TBI
$1,236,188William E Haskins · Gryphon Bio, Inc. · R44 · FY2025 · NS
Surgery Branch Cell Prep Core
$1,236,025John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Cell Production Core Facility
$1,236,025Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Translational Applications of mda-7/IL-24 in Cancer
$1,235,688Paul B Fisher · Columbia University Health Sciences · P01 · FY2007 · CA
Antigen Processing And Presentation In The Intestine
$1,235,645Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Stem cells for therapeutics discovery in genetic blood disorders
$1,235,586George Q Daley · Boston Children'S Hospital · U01 · FY2020 · HL
NF Center: from animal models to therapeutics
$1,235,539Luis F Parada · Ut Southwestern Medical Center · P50 · FY2011 · NS
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
$1,235,411Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2021 · AI